Patents Assigned to ADRX, INC.
  • Tau aggregation peptide inhibitors
    Patent number: 11453701
    Abstract: This invention relates to the field of tau aggregation inhibitors. More specifically, the invention relates to amyloid therapeutics. More specifically, the invention provides pharmaceutical compositions and methods of treating aggregation associated conditions or diseases with certain peptides.
    Type: Grant
    Filed: August 20, 2018
    Date of Patent: September 27, 2022
    Assignee: ADRX, INC.
    Inventors: Shiho Tanaka, Ashley Wright, James Treanor, Marcin Apostol, Matthew A. G. Graf
  • Peptide inhibitors of transcription factor aggregation
    Patent number: 11117930
    Abstract: This invention relates to materials, such as peptides, and methods to inhibit the aggregation transcription factors, for example p53 inhibitors, p63 inhibitors and p73 inhibitors. More specifically, the invention relates to cancer chemotherapeutics. More specifically, the invention provides pharmaceutical compositions and methods of treating cancer with certain peptides.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: September 14, 2021
    Assignee: ADRX, INC.
    Inventors: Shiho Tanaka, Ashley Wright, James Treanor, Marcin Apostol